Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, for the month of December 2022. The filing, dated December 28, 2022, serves to distribute a press release (Exhibit 99.1) to U.S. investors. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text does not contain specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document. The filing acts solely as a conduit for the attached press release.
Material Changes
The filing text does not provide details on material changes versus prior periods. Specific operational or financial changes are contained within the referenced press release (Exhibit 99.1), the content of which is not included in the input text.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the cover page of this filing. These elements, if present, would be located in the attached press release.
Key Facts for Investor Verification
- Verify the content of the attached Press Release dated December 28, 2022 (Exhibit 99.1) for specific corporate announcements.
- Confirm that no financial statements or quantitative metrics are included in this specific Form 6-K cover document.
- Note that the filing is signed by André Choulika, Chief Executive Officer.